Class 424/213.1 - Canine distemper virus

Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the virus is a canine distemper virus.
No. of patents: 25
Last issue date: 08/11/2009

Number	Title	Issue Date
7572454	T helper cell epitopes The present invention provides T helper cell epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of SSKTQTHTQQDRPPQPS (SEQ...	08/11/2009
7241448	T helper cell epitopes The present invention provides T helper cell epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of EPINQALTLMTKNVKPL (SEQ...	07/10/2007
7208163	Method for producing temperature-sensitive morbillivirus It was found that a mutation of an amino acid at a specific position in the P protein of a morbillivirus gives a temperature-sensitivity character to a virus. By introducing this mutation, a virus to which a temperature-sensitivity character has been introduced can ...	04/24/2007
7097844	T helper cell epitopes The present invention provides T helper cell epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of PRTSDRPVSYTMNRTRS (SEQ...	08/29/2006
7037507	T helper cell epitopes The present invention provides T helper cell epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of SSKTQTHTQQDRPPQPS (SEQ...	05/02/2006
6875436	Method for producing cell-fushion type morbillivirus mutants It was found that a mutation of an amino acid at a specific position in the F protein of a morbillivirus induces a reduction in the cell-fusion ability. By introducing this mutation, a virus having a reduced cell-fusion ability can be produced. Thus, attenuat...	04/05/2005
6685947	T helper cell epitopes The present invention provides T helper cells epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of SSKTQTHTQQ...	02/03/2004
6656719	Serum-free, low-protein media for rotavirus vaccine production Defined serum-free, low protein media (LPKM), that supports 1) Vero cell growth for up to 20 passages, 2) Vero cell growth on microcarriers and 3) rotavirus production is provided. Maximum cell densities attained are 60-100% of that in serum-containing me...	12/02/2003
6383741	Method for treatment of canine distemper The present invention relates to a treatment for animals having canine distemper by administering a composition comprising an attenuated canine distemper virus a sub-vaccine virus level effective to alleviate symptoms canine distemper. The invention also ...	05/07/2002
6309647	Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants Attenuated recombinant viruses containing DNA coding for a canine distemper virus antigen or measles M or N antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recomb...	10/30/2001
6159477	Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus Disclosed and claimed is a recombinant canine herepes virus (CHV). The recombinant CHV includes and expresses at least one heterologous nucleotide sequence encoding an antigen. The antigen can be canine distemper virus HA, canine distemper virus F, rabies...	12/12/2000
5807840	Method for treating canine distemper The present invention discloses a method for treating patients having the CDV associated symptoms or animals carrying or infected by the canine distemper virus (CDV) or having antibodies against the CDV using Product R, a peptide-nucleic acid preparation....	09/15/1998
5756102	Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants Attenuated recombinant viruses containing DNA coding for a canine distemper virus antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can...	05/26/1998
5750112	Canine coronavirus vaccine from feline enteric coronavirus This invention provides a vaccine which contains, per dose, an effective immunizing amount of an inactivated feline enteric coronavirus and a suitable carrier. The vaccine of this invention may also contain an adjuvant, an effective immunizing amount of a...	05/12/1998
5538733	Method of priming an immune response in a one-day old animal The invention provides a method of priming an immune response in the presence of maternal antibody in a young animal by administering to a 1-90 day old animal, a biocompatible and non-toxic solid phase implant containing an immunogenic agent. A preferred ...	07/23/1996
5503834	Measles virus recombinant poxvirus vaccine What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embo...	04/02/1996
5178862	Canine distemper virus vaccine and method of preparation Disclosed is a vaccine for the prevention of disease caused by canine distemper virus (CDV). The vaccine is prepared from CDV immunogens derived from CDV persistently-infected cells cultured in vitro. CCL-64 mink lung cells are the preferred cell line. CD...	01/12/1993
5000951	Multivalent canine distemper virus vaccine A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable i...	03/19/1991
4992272	Canine distemper virus vaccine A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable i...	02/12/1991
4990367	Canine distemper virus vaccine A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable i...	02/05/1991
4358438	Novel polyvalent virus vaccine against rabies and canine distemper A polyvalent virus vaccine for immunization of warm-blooded animals comprising a mixture of a rabies virus, preferably rabies strain No. 675 deposited in the Czechoslovak National Collection of Type Cultures of the Institute of Hygiene and Epidemiology in...	11/09/1982
4351827	Novel polyvalent virus vaccine A polyvalent virus vaccine for immunization of warm-blooded animals comprising a mixture of a rabies virus, preferably rabies strain No. 675 deposited in the Czechoslovak National Collection of Type Cultures of the Institute of Hygiene and Epidemiology in...	09/28/1982
4112068	Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom A finite cell strain is derived from canine fetal lung tissue, the cells of which are fibroblast-like, diploid, and are free of reverse transcriptase and C-type particles. With a nutrient medium the cells provide a cell culture system useful in the cultiv...	09/05/1978
4071618	Process for preparing virus disease live vaccines Process for preparing a virus disease live vaccine by employing culture of a quail embryonated egg or tissue culture of a quail embryo fibroblast for cultivation of the virus. The vaccine obtained according to the present invention is effective for immuni...	01/31/1978
4004974	Live virus culture vaccine against carnivore distemper and method of producing same A live virus culture vaccine against carnivore distemper. Said vaccine is an attenuated strain of the carnivore distemper virus adapted to a cell culture of the kidney tissue of green monkeys and cultivated in said culture. The method of producing said vaccine...	01/25/1977

PatentStorm

Quotables

PatentStorm News

Class 424/213.1 - Canine distemper virus